Pharma "cannot fix" health inequalities on its own, global industry body declares
This article was originally published in Scrip
Executive Summary
This week (20 - 22 September) in New York, while world leaders attend a UN high-level summit to help accelerate progress towards the Millennium Development Goals (MDGs), the body that represents the pharmaceutical industry around the world, the IFPMA, has reminded them that pharma does good deeds, too. However, some critics say the industry needs to do more.